Tumors of the Thymus and Thymic Region: I. Clinicopathological Studies on Thymomas

https://doi.org/10.1016/S0003-4975(10)63498-4Get rights and content

Abstract

A series of 43 patients with thymoma was reviewed. The patients were classified with respect to some factors of prognostic significance. The tumors were reclassified histologically, and a staging system with three defined stage-groups was applied to the series on the basis of operative findings and histological examination of surgical specimens. Surgical-pathological staging is of high prognostic and therapeutic importance in thymomas.

Complete removal of the tumor was possible in the 25 patients with stage I or II disease and in 14 of the 18 patients with stage III tumors. Pleural metastases were observed in half of the patients with stage III disease. Even patients with extensive local spread or pleural metastases were subjected to tumor resection. The treatment of choice is radical resection alone in stage I; radical extirpation and, if indicated, post-operative radiotherapy in stage II; and radical resection whenever possible, even in cases of pleural spread, in stage III, with postoperative radiotherapy and chemotherapy. Myasthenia gravis is an indication rather than a contraindication to radical treatment of thymoma, although some patients may deteriorate. The importance of total thymectomy is stressed.

References (18)

There are more references available in the full text version of this article.

Cited by (181)

  • Thymoma: a clinicopathological correlation of 1470 cases

    2018, Human Pathology
    Citation Excerpt :

    However, an important fact that has been largely ignored or overlooked, mainly by those who support the histological classification as a predictor of outcome, is tumor sampling, an issue that was raised more than a decade ago [2]. With regard to the staging system of thymomas, recognizing that there are several proposed in the literature [25-30], the one that has been most widely adopted is that proposed by Masaoka et al [31] and modified by Koga et al [32], despite the fact that the system poses some problems regarding its application and that some even have called for a new system [33,34]. In the meta-analysis conducted by Gupta et al [34], the authors noted a lack of statistically significant differences between Masaoka stages I and II, suggesting that those staging categories may not provide significant clinical value.

  • Thymic Tumors

    2018, IASLC Thoracic Oncology
  • Thymoma and thymic carcinomas

    2016, Critical Reviews in Oncology/Hematology
  • Uncommon Thoracic Tumors

    2015, Clinical Radiation Oncology
  • Staging of thymic epithelial neoplasms: Thymoma and thymic carcinoma

    2015, Pathology Research and Practice
    Citation Excerpt :

    Herein we provide an overview of the history of staging these tumors with special emphasis on recent advances in this field. In 1978, Bergh et al. [9] presented one of the first staging attempts for thymic epithelial neoplasms investigating 43 thymomas. They devised a system with 3 stage groups and based their classification on operative findings and histological examination (Table 1):

View all citing articles on Scopus
View full text